HT29 factor

soluble substance produced by HT29 colon cancer cells; markedly suppresses mitogen-induced T-cell proliferation and IL-2 production

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Colonic Neoplasms (Colon Cancer) 10/01/1990 - "A soluble substance (HT29 factor) produced by HT29 colon cancer cells markedly suppresses mitogen-induced T-cell proliferation and interleukin-2 production. " 04/01/1987 - "The colon cancer cell line, HT29, produces a soluble substance (HT29 factor) that blocks mitogen-induced T cell proliferation and the production of interleukin 2 (IL 2). "
2.	Neoplasms (Cancer) 10/01/1990 - "Serum-free conditioned medium was collected from confluent cultures of HT29 cancer cells, concentrated, and subjected to gel filtration chromatography and anion exchange chromatography, resulting in 24.4-fold purification of the HT29 factor with 31% yield. "